India approves emergency use of remdesivir to treat Covid-19 patients
Skip to main content
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
  • Epaper
  • More
    • Subscribe
    • COVID-19
    • Bangladesh
    • Splash
    • Videos
    • Games
    • Long Read
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
The Business Standard

Friday
July 01, 2022

Sign In
Subscribe
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
  • Epaper
  • More
    • Subscribe
    • COVID-19
    • Bangladesh
    • Splash
    • Videos
    • Games
    • Long Read
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
FRIDAY, JULY 01, 2022
India approves emergency use of remdesivir to treat Covid-19 patients

Coronavirus chronicle

Reuters
02 June, 2020, 03:50 pm
Last modified: 02 June, 2020, 04:12 pm

Related News

  • How an 'inflammatory' Facebook post led to a killing and sectarian tension in India
  • Nupur Sharma 'single-handedly responsible for what's happening' in country: Indian SC
  • There is reason to be afraid: Nobel laureate Amartya Sen on India's situation
  • India raises import tax on gold to 12.5% from 7.5%
  • Thousands march in India's Udaipur to demand protection for Hindus after tailor slaughtered

India approves emergency use of remdesivir to treat Covid-19 patients

As of Tuesday, India has 198,706 cases of coronavirus and has recorded 5,598 deaths

Reuters
02 June, 2020, 03:50 pm
Last modified: 02 June, 2020, 04:12 pm
Photo: Collected
Photo: Collected

India's government said on Tuesday it has approved Gilead Sciences Inc's antiviral drug remdesivir for emergency use in treating Covid-19 patients.

Remdesivir is the first drug to show improvement in Covid-19 patients in formal clinical trials. It was granted emergency use authorization by the US Food and Drug Administration last month and has received approval by Japanese health regulators.

"(Remdesivir) approved on June 1 under emergency use with condition for five dose administration," the Drugs Controller General of India said in an email statement.

The drugmaker did not immediately respond to an email seeking further details.

As of Tuesday, India has 198,706 cases of coronavirus and has recorded 5,598 deaths, health ministry data showed https://www.mohfw.gov.in.

Gilead Sciences had on Monday reported that remdesivir showed modest benefit in patients with moderate Covid-19 given a five-day course, while those who received it for 10 days in the study did not fare as well.

European and South Korean authorities are also looking at remdesivir, with South Korean health authorities last Friday saying they would request imports of the drug. Gilead is yet to gain regulatory approval in either market.

Top News / South Asia

India / Coronavirus

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • EU’s REX system: Exporters now enjoy hassle-free certification of goods origin
    EU’s REX system: Exporters now enjoy hassle-free certification of goods origin
  • BB bids farewell to easy money policy to tame inflation
    BB bids farewell to easy money policy to tame inflation
  • Photo: Collected
    Daily Covid deaths rise to 5

MOST VIEWED

  • Former North Korean defectors living in South Korea, release balloons containing one dollar banknotes, radios, CDs and leaflets denouncing the North Korean regime, towards the north near the demilitarized zone which separates the two Koreas in Paju, north of Seoul January 15, 2014. REUTERS/Kim Hong-Ji/File Photo
    North Korea blames 'alien things' near border with South for Covid outbreak
  • People wearing protective face masks commute amid concerns over the new coronavirus disease (COVID-19) in Pyongyang, North Korea March 30, 2020, in this photo released by Kyodo. Picture taken March 30, 2020. Mandatory credit Kyodo/via REUTERS
    S Korea says leaflets sent by defectors unlikely to be cause of Covid in N Korea
  • Test tubes are seen in front of displayed Pfizer and Biontech logos in this illustration taken, May 21, 2021. Reuters: llustration
    BioNTech, Pfizer to start testing universal vaccine for coronaviruses
  • A woman holds a small bottle labelled with a "Coronavirus COVID-19 Vaccine" sticker and a medical syringe in this illustration taken October 30, 2020. REUTERS/Dado Ruvic/File Photo
    S Korea approves first domestically developed Covid vaccine
  • Photo: Collected
    US medical experts call for Omicron-specific Covid boosters
  • David E Adler. Sketch: TBS
    Who managed Covid-19 best, and why?

Related News

  • How an 'inflammatory' Facebook post led to a killing and sectarian tension in India
  • Nupur Sharma 'single-handedly responsible for what's happening' in country: Indian SC
  • There is reason to be afraid: Nobel laureate Amartya Sen on India's situation
  • India raises import tax on gold to 12.5% from 7.5%
  • Thousands march in India's Udaipur to demand protection for Hindus after tailor slaughtered

Features

Photo: Collected

Sapiens – A Graphic History 

4h | Book Review
Black-naped Monarch male  Photo: Enam Ul Haque

Black-naped Monarch: A sovereign who never abandoned the Indian subcontinent

5h | Panorama
The 136-year-old company on its last legs

The 136-year-old company on its last legs

6h | Features
Agricultural worker walks between rows of vegetables at a farm in Eikenhof, south of Johannesburg, South Africa. Photo: Reuters

With vast arable lands, why is Africa dependent on imported grain?

3h | Panorama

More Videos from TBS

Dhaka University celebrating 102nd founding anniversary today

Dhaka University celebrating 102nd founding anniversary today

4h | Videos
Ctg Int'l Trade Fair returns after a 2-year hiatus without Covid restrictions

Ctg Int'l Trade Fair returns after a 2-year hiatus without Covid restrictions

5h | Videos
Bangladeshis among top 6 nationalities seeking asylum in Europe

Bangladeshis among top 6 nationalities seeking asylum in Europe

5h | Videos
RUET organises Robotronics 2.0

RUET organises Robotronics 2.0

6h | Videos

Most Read

1
Padma Bridge from satellite. Photo: Screengrab
Bangladesh

Padma Bridge from satellite 

2
Meet the man behind 'Azke amar mon balo nei'
Splash

Meet the man behind 'Azke amar mon balo nei'

3
Photo: TBS
Bangladesh

Motorcycles banned on Padma Bridge 

4
Photo: Collected
Economy

Tech startup ShopUp bags $65m in Series B4 funding

5
Photo: Courtesy
Corporates

Gree AC being used in all parts of Padma Bridge project

6
World Bank to give Bangladesh $18b IDA loans in next five years
Economy

World Bank to give Bangladesh $18b IDA loans in next five years

EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2022
The Business Standard All rights reserved
Technical Partner: RSI Lab
BENEATH THE SURFACE
Workers with minimum safety equipment are busy producing iron rods at a local re-rolling mill at Postogola in Old Dhaka. Reused metals from the adjacent shipyards in Keraniganj have played a major role in establishing several such mills in the area. PHOTO: Mumit M

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net